Thu 22 Oct 2026 20:28:01 BST
Search Company
*

Active Substance
New Active Substance
Search Site
--
*

Create Site
--
*
*
*
*
*
*
Update Site
Current data stored in EudraGMDP databaseCurrent data stored in OMS
--
Characters remaining:4000/4000
New Active Substance Importation
Active Substance*
Active Substance (English):
Active Substance (NL):
NCA Reference Key:
3rd Country Manufacturer
3rd Country ManufacturerOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

3rd Country Distributor
3rd Country DistributorOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

Information Messages
  • The WDA has been withdrawn, withdrawn date is: 2025-03-07
  • RTF Template


    National Agency For The Safety Of Medicine And Health Products

    UNION FORMAT FOR A WHOLESALE DISTRIBUTION AUTHORISATION

    Human medicinal products


    1. Authorisation Number

    :

    2023_141_1_2_4

    2. Name of Authorisation Holder

    :

    Sanofi Pasteur

    (ORG-100000788 / LOC-100010589)

    3. Address(es) of Site(s)

    :

    Parc Industriel D Incarville, Voie De L Institut, P. O. Box 101, Val De Reuil, 27100, France 




    4. Legally registered address of Authorisation Holder

    :

    14 Espace Henry Vallee, Lyon, 69007

    5. Scope of authorisation

    :

    ANNEX 1

    6. Legal basis of authorisation

    :

    Art. 77(1) of Directive 2001/83/EC

    7. Name of responsible officer of the competent authority of the member state granting the wholesale distribution authorisation

    :

    Confidential, Confidential

    8. Signature

    :


    9. Date

    :

    2023-09-27

    10. Annexes attached

    :

    Annex 1 Scope of wholesale distribution authorisation

    Annex 2 (Optional) Address(es) of contract wholesale distribution sites and their authorisation number

    Annex 3 (Optional) Name(s) of responsible person(s)

    Annex 4 (Optional) Date of Inspection on which authorisation was granted

    Annex 5 (Optional) Additional provisions based on national requirements


    ANNEX 1

    SCOPE OF WHOLESALE DISTRIBUTION AUTHORISATION



    Name and address of the site: Sanofi Pasteur

    (ORG-100000788 / LOC-100000593)

    , Parc Industriel D Incarville, Voie De L Institut, P. O. Box 101, Val De Reuil, 27100, France   



    Human medicinal products


    1. MEDICINAL PRODUCTS

       1.1. with a Marketing Authorisation in EEA country(s)

       1.2. without a Marketing Authorisation in the EEA and intended for EEA market


    2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

       2.2. Holding 

       2.3. Supply 

       2.4. Export 


    3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

         3.1.3. Immunological medicinal products 

       3.3. Cold chain products(requiring low temperature handling) 




    Any restrictions or clarifying remarks (for all users):  -
    Dépositaire (Public Health Code Article R.5124-2 4°)
    acting by order and on behalf of:
    - one or more "exploitants" of medicinal products, generators, kits and precursors (Article L.4211-1 3°),
    - one or more manufacturers or importers of dressing objects or articles presented as complying with the French pharmacopoeia mentioned in Article L.4211-1 2°,
    activity: storage with a view to the wholesale distribution without modification of medicines, products, objects or articles not owned by the company.

    Signatory: Mrs Florence Descamps-Delesalle, head of pharmaceutical product inspection and counterfeiting fight department
    The ANSM does not issue hard copy of this authorisation.
    ---

    Etablissement dépositaire (code de la santé publique art. R.5124-2 4°) se livrant, d'ordre et pour le compte :
    -d'un ou plusieurs exploitants de médicaments, de générateurs, trousses ou précurseurs (art. L.4211-1 3°),
    -ou d'un ou plusieurs fabricants ou importateurs d'objets de pansement ou articles présentés comme conformes à la Pharmacopée cités à l'art. L.4211-1 2°,
    au stockage de ces médicaments ou produits, objets ou articles dont elle n'est pas propriétaire, en vue de leur distribution en gros et en l'état.

    Signataire : Mme Florence Descamps-Delesalle, chef du Pôle inspection des produits pharmaceutiques et lutte contre les fraudes
    L'ANSM ne délivre pas de copie papier de cette autorisation.








    Reason for Withdrawing:

    replaced by Decision 2025_107_1_2_4

    remplacée par la décision 2025_107_1_2_4








    Union Format for a Wholesale Distribution Authorisation

    2023_141_1_2_4


    Page 1





    Loading, please wait